Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PAPZIMEOS™ safely and effectively. See full prescribing information for PAPZIMEOS. PAPZIMEOS (zopapogene imadenovec-drba) suspension for subcutaneous injectionInitial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
PAPZIMEOS is indicated for the treatment of adults with recurrent respiratory papillomatosis.
- generic_name
- zopapogene imadenovec
- product_names
- zopapogene imadenovec
- ndc
- 84768-511, 84768-511-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en